Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of turoctocog alfa in paediatric previously untreated patients with haemophilia A
2011-001033-16Phase 3Terminated
- Sponsor
- Novo Nordisk
- Start
- Aug 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of turoctocog alfa in hemophilia A, sponsored by Novo Nordisk. Started Aug 2011; status: terminated.
02
Drugs
turoctocog alfa
03
Conditions
hemophilia A
Beyond the preview
Go deeper on 2011-001033-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001033-16.